Ticker LaunchSPAC · Liquidated
Monterey Bio Acquisition Corp
Monterey Bio Acquisition Corp is a blank-check company (SPAC) that raised $100M in its initial public offering on Oct 4, 2021, listing on Nasdaq Global Market. It did not complete a business combination and liquidated around Nov 20, 2023, returning the trust to public shareholders. Chardan led the IPO. Greenberg Traurig advised the SPAC and Reed Smith advised the underwriters on the IPO.
- Status
- Liquidated
- IPO date
- Oct 4, 2021
- IPO size
- $100M
- IPO exchange
- Nasdaq Global Market
- IPO underwriters
- Chardan
- SPAC counsel (IPO)
- Greenberg Traurig
- Underwriters' counsel (IPO)
- Reed Smith
More on this SPAC for subscribers
- Trust balance and value per share
- Liquidation deadline and extension history
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Oct 4, 2021
- All filings on EDGAR CIK 1860663
Other SPAC IPOs from 2021
- Focus Impact BH3 Acquisition Co (formerly Crixus BH3 Acquisition Co)Oct 6, 2021 · $200M
- Parsec Capital Acquisitions Corp.Oct 6, 2021 · $75M
- Mount Rainier Acquisition Corp.Oct 5, 2021 · $150M
- Marblegate Acquisition Corp.Oct 4, 2021 · $300M
- TdMY Technology Group, Inc.Oct 4, 2021 · $210M
- Artemis Strategic Investment CorpOct 1, 2021 · $175M